Table 1.
Patient, Tumor, and Treatment Characteristics of the Initial Patient Group, New Patient Group, and All Patients
Initial Group (n = 54) |
New Group (n = 86) |
All Patients (N = 140) |
|||||
---|---|---|---|---|---|---|---|
Characteristic | No. | % | No. | % | No. | % | P * |
Age, years | |||||||
Mean | 57.8 | 60.4 | 59.4 | .24† | |||
Sex | |||||||
Male | 74 | 84.9 | 80.7 | .12‡ | |||
Tumor site | .34‡ | ||||||
Oral cavity | 11 | 20 | 16 | 19 | 27 | 19 | |
Oropharynx | 31 | 57 | 39 | 45 | 70 | 50 | |
Hypopharynx | 8 | 15 | 22 | 26 | 30 | 22 | |
Other | 4 | 7 | 9 | 11 | 13 | 9 | |
Tumor volume, cm2 | |||||||
Mean | 27.5 | 20.9 | 23.7 | .03† | |||
Not available | 5 | 18 | |||||
T stage | .54‡ | ||||||
0–2 | 27 | 50 | 47 | 55 | 74 | 53 | |
3–4 | 27 | 50 | 39 | 45 | 66 | 47 | |
N stage | .07‡ | ||||||
0 | 7 | 13 | 21 | 25 | 28 | 20 | |
1 | 1 | 2 | 6 | 7 | 7 | 5 | |
2 | 35 | 65 | 51 | 59 | 86 | 61 | |
3 | 11 | 20 | 8 | 9 | 19 | 14 | |
Stage | .02‡ | ||||||
I-II | 2 | 4 | 14 | 16 | 16 | 12.5 | |
III-IV | 52 | 96 | 72 | 84 | 124 | 88.5 | |
Hemoglobin, g/dL | |||||||
Mean | 13.7 | 13.6 | 13.6 | .8† | |||
OPN level, ng/mL | |||||||
Mean | 490.6 | 559.3 | 532.8 | .11† | |||
Median | 440.3 | 532.0 | 496.0 | ||||
Surgery for primary | 35 | 42 | 39 | .48‡ | |||
Neck dissection | 41 | 40 | 40 | .93‡ | |||
Radiotherapy | 93 | 78 | 83 | .01‡ | |||
Chemotherapy | 74 | 64 | 68 | .20‡ | |||
Mean follow-up, months | .003† | ||||||
All patients | 39 | 27 | 32 | < .0001† | |||
Living patients | 63 | 38 | 47 | ||||
Patients with uncontrolled tumor | 3 | 6 | 8 | 9 | 11 | 8 | .42‡ |
Patients with relapse | 23 | 43 | 27 | 31 | 50 | 36 | .23‡ |
Patients who died | 29 | 54 | 37 | 43 | 66 | 47 | .22‡ |
Abbreviation: OPN, osteopontin.
P = between initial and new groups.
t test P.
χ2P.